Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
  1. Home
  2. Publications
  3. Supplementary Figure S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Supplementary Figure S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors

Authors:
  • Francesco Facchinetti
    Francesco Facchinetti
  • Antoine Hollebecque
    Antoine Hollebecque
  • Rémy Barbé
    Rémy Barbé
  • Dong Man Jang
    Dong Man Jang
  • BABeatriz Alonso-De-Castro
    Beatriz Alonso-De-Castro
  • FBFloriane Brayé
    Floriane Brayé
  • LBLudovic Bigot
    Ludovic Bigot
  • CNCatline Nobre
    Catline Nobre
  • ASAlice Da Silva
    Alice Da Silva
  • MMMélissandre Méteau
    Mélissandre Méteau
  • MDMathis Delavigne
    Mathis Delavigne
  • MSMiguel Soares
    Miguel Soares

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.32708710
Abstract
Primary resistance to lirafugratinib in FGFR inhibitor-naïve patients.
Keywords
  • TUMORS PRIMARY
  • SUPPLEMENTARY FIGURE
  • INFORM TREATMENT
  • TREATMENT SEQUENCING
  • LIRAFUGRATINIB INFORM
  • RECURRENT RESISTANCE
  • RESISTANCE MUTATIONS
  • PRIMARY RESISTANCE
  • FGFR INHIBITOR-NAÏVE
  • INHIBITOR-NAÏVE PATIENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.